← 홈

프로그램 비교

타깃 · 모달리티 · 임상 근거 · 비임상 맥락으로 최대 5개 프로그램을 나란히 비교합니다. · 다음 갱신 D-5 · 마지막 9월 2일

현재 선택: 1개 · 임상 갱신 필요 1개

프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.

프로그램 선택

API CSV15행 · 1개 프로그램
OverviewToxicologyClinical

표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.

항목
CGTStandard DatabasestalePhase 1
NKG2D CAR-NK (NKG2D CAR-NK)
Nkarta, Inc.·AML
14 trials
Overview
Program
NKG2D CAR-NK
Overview
Company
Nkarta, Inc.
Overview
Modality
CGT
Overview
Target
AML
Overview
Indication
Refractory Metastatic Colorectal Cancer
Overview
Phase
PHASE_1
Overview
Status
ACTIVE
Overview
Content status
Standard Database
Overview
Data Confidence
Data Confidence · Medium
Overview
Development Signal
Development Signal · Watch
Overview
Approval status
Investigational
Toxicology
Major finding
Intraperitoneal infusion of NKG2D CAR-NK cells induces endogenous CD8 + T cell activation in patients with advanced colorectal cancer.. Peritoneal metastasis (PM) is a prevalent mode of metastasis in colorectal cancer (CRC) with rapid disease progression and limited treatment options. Locoregional infusion of immune cells have been explored in different types of solid tumors, but the feasibility a…
Toxicology
CRS
Reported
Clinical
Safety signal
Intraperitoneal infusion of NKG2D CAR-NK cells induces endogenous CD8 + T cell activation in patients with advanced colorectal cancer.. Peritoneal metastasis (PM) is a prevalent mode of metastasis in colorectal cancer (CRC) with rapid disease progression and limited treatment options. Locoregional infusion of immune cells have been explored in different types of solid tumors, but the feasibility a…
Clinical
Program phase
PHASE_1